[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"percutaneous-transluminal-coronary-angioplasty\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:percutaneous-transluminal-coronary-angioplasty":26},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,3,0,[8,43,75],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":4,"briefSummary":23,"conditions":24,"keywords":27,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":31,"lastUpdatePostDateStruct":32,"startDateStruct":35,"completionDateStruct":37,"leadSponsor":39,"locationsCount":42},"100147099","evaluation-of-the-first-second-and-new-drug-eluting-stents-in-routine-clinical-practice-100147099",false,"NCT01186133","Evaluation of the First, Second, and New Drug-Eluting Stents in Routine Clinical Practice","Evaluation of Effectiveness and Safety of the First, Second, and New Drug-Eluting Stents in Routine Clinical Practice","IRIS-DES","Inclusion Criteria:\n\n* coronary disease amenable to percutaneous coronary intervention (PCI)\n* no clinical and lesion limitations\n\nExclusion Criteria:\n\n* patients with a mixture of several DES\n* terminal illness with life expectancy less than 1 year\n* patients with cardiogenic shock","ALL","19 Years",{"count":20,"type":21},50000,"ESTIMATED","OBSERVATIONAL","The objective of this study is to evaluate effectiveness and safety of the new drug-eluting stent (DES), as compared with the first-,second-,third-, and fourth-generation DES, in the \"real world\" daily practice.",[25,26],"Coronary Artery Disease","Percutaneous Transluminal Coronary Angioplasty",[28,29],"coronary disease","drug eluting stent","RECRUITING","2026-06-26",{"date":33,"type":34},"2026-06-30","ACTUAL",{"date":36,"type":4},"2009-01",{"date":38,"type":21},"2030-12",{"name":40,"class":41},"Seung-Jung Park","OTHER",1,{"id":44,"slug":45,"hasResults":11,"nctId":46,"briefTitle":47,"officialTitle":47,"acronym":4,"eligibilityCriteria":48,"healthyVolunteers":11,"sex":17,"minAge":49,"maxAge":4,"enrollmentInfo":50,"targetDuration":4,"studyType":22,"phases":4,"briefSummary":52,"conditions":53,"keywords":61,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":65,"lastUpdatePostDateStruct":66,"startDateStruct":68,"completionDateStruct":70,"leadSponsor":72,"locationsCount":42},"100513945","integration-of-telemedicine-and-home-based-cardiac-rehabilitation-feasibility-efficacy-and-adherence-100513945","NCT05972070","Integration of Telemedicine and Home-Based Cardiac Rehabilitation: Feasibility, Efficacy, and Adherence","Inclusion Criteria:\n\n1. Over the age of 18\n2. NYHA Functional Class I, II,\n3. Recent (within 60 days) status post coronary artery revascularization for atherosclerotic coronary artery disease (coronary artery bypass grafting or percutaneous coronary revascularization with stent implantation)\n4. Candidate for traditional center-based cardiac rehabilitation\n\nExclusion Criteria:\n\n1. Under the age of 18\n2. Adults lacking capacity to consent.\n3. NYHA Functional Class III, IV\n4. Acute coronary syndrome\n5. Systolic heart failure (LV EF \\\u003C40%)\n6. Status post cardiac surgery for structural heart disease or heart transplant\n7. Percutaneous coronary angioplasty\n8. Adults lacking capacity to consent.\n9. Pregnant women","18 Years",{"count":51,"type":21},500,"The aim of this study is to evaluate feasibility, efficacy, and adherence of home-based cardiac rehabilitation with the integration of telemedicine. Several components will be assessed such as quality-of-life, nutritional counseling, maximum metabolic activity (MET's), diabetic management, tobacco cessation, lipid, blood pressure, and psychosocial management. These tasks will be accomplished through concurrent conversations between patients and their therapist's utilizing telemedicine with observed exercise training.",[54,26,55,56,57,58,59,60],"Myocardial Infarction","Coronary Artery Bypass","Stable Angina","Heart Failure","Valve Disease, Heart","Cardiac Rehabilitation","Stent",[62,63,64],"Cardiac rehabilitation","Home based cardiac rehabilitation","Telemedicine and Home-Based Cardiac Rehabilitation","2025-07-21",{"date":67,"type":34},"2025-07-24",{"date":69,"type":34},"2023-06-01",{"date":71,"type":21},"2025-12-31",{"name":73,"class":74},"ROM Technologies, INC","INDUSTRY",{"id":76,"slug":77,"hasResults":11,"nctId":78,"briefTitle":79,"officialTitle":79,"acronym":80,"eligibilityCriteria":81,"healthyVolunteers":11,"sex":17,"minAge":82,"maxAge":4,"enrollmentInfo":83,"targetDuration":4,"studyType":22,"phases":4,"briefSummary":85,"conditions":86,"keywords":91,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":100,"lastUpdatePostDateStruct":101,"startDateStruct":103,"completionDateStruct":105,"leadSponsor":107,"locationsCount":42},"100301846","frailty-syndrome-in-daily-practice-of-interventional-cardiology-ward-100301846","NCT03209414","Frailty Syndrome in Daily Practice of Interventional Cardiology Ward","FRAPICA","Inclusion Criteria:\n\n* aged ≥ 65\n* symptomatic coronary artery disease A) stable B) unstable C) NSTEMI D) STEMI\n* written, informed consent\n\nExclusion Criteria:\n\n* lack of consent","65 Years",{"count":84,"type":21},1000,"The impact of frailty on immediate and long term outcomes of invasive treatment of coronary artery disease is not fully characterized. The assessment of frailty may help physicians in the selection of best treatment option and in the timing and modality of the follow-up. The FRAilty syndrome in daily Practice of Interventional CArdiology ward (FRAPICA) study is designed with the aim to validate the use of the Fried frailty scale and instrumental activities of daily living scale (IADL) as prognostic tools in patients admitted to hospital for symptomatic coronary artery disease, either stable, unstable, or acute coronary syndrome (ACS).\n\nThe FRAPICA study is a single center prospective study enrolling patients aged ≥65 years. The aims are (1) to describe Fried frailty scale and IADL scale distribution before hospital discharge and (2) to investigate the prognostic role of Fried frailty and IADL scores. The outcomes are: (1) results of invasive treatment, (2) its complications (periinterventional MI, contrast-induced nephropathy, blood loss), (3) three-year all-cause mortality, cardiovascular mortality, stroke, myocardial infarction, reintervention, heart failure, hospital readmission for any cause, and a composite of the above mentioned. Ancillary analyses will be focused on different clinical presentations, different tools to assess frailty and risk stratification.\n\nThe FRAPICA program will fill critical gaps in the understanding of the relation between frailty, cardiovascular disease, interventional procedures and outcome. It will enable more personalized risk assessment and identification of new targets for interventions.",[87,88,89,90,26],"Frail Elderly Syndrome","Coronary Heart Disease","Acute Coronary Syndrome","Coronary Artery Bypass Grafting",[92,93,94,95,96,97,98,99],"Frailty syndrome","Coronary heart disease","Coronary revascularization","Major adverse cardiovascular events","Arterial stiffness","Applanation tonometry","Lean body mass","ST2 biomarker","2023-04-10",{"date":102,"type":34},"2023-04-12",{"date":104,"type":34},"2017-05-17",{"date":106,"type":21},"2027-12-31",{"name":108,"class":41},"Medical University of Silesia"]